Guo Congting, Ma Xiaoteng, Gao Fei, Guo Yuxuan
School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Peking University Institute of Cardiovascular Sciences, Beijing, China.
Front Bioeng Biotechnol. 2023 Mar 9;11:1143157. doi: 10.3389/fbioe.2023.1143157. eCollection 2023.
Gene editing stands for the methods to precisely make changes to a specific nucleic acid sequence. With the recent development of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, gene editing has become efficient, convenient and programmable, leading to promising translational studies and clinical trials for both genetic and non-genetic diseases. A major concern in the applications of the CRISPR/Cas9 system is about its off-target effects, namely the deposition of unexpected, unwanted, or even adverse alterations to the genome. To date, many methods have been developed to nominate or detect the off-target sites of CRISPR/Cas9, which laid the basis for the successful upgrades of CRISPR/Cas9 derivatives with enhanced precision. In this review, we summarize these technological advancements and discuss about the current challenges in the management of off-target effects for future gene therapy.
基因编辑是指对特定核酸序列进行精确改变的方法。随着成簇规律间隔短回文重复序列(CRISPR)/Cas9系统的最新发展,基因编辑已变得高效、便捷且可编程,为遗传疾病和非遗传疾病带来了前景广阔的转化研究和临床试验。CRISPR/Cas9系统应用中的一个主要问题是其脱靶效应,即对基因组产生意外、有害甚至不良的改变。迄今为止,已经开发出许多方法来识别或检测CRISPR/Cas9的脱靶位点,这为成功升级精度更高的CRISPR/Cas9衍生物奠定了基础。在本综述中,我们总结了这些技术进展,并讨论了未来基因治疗中脱靶效应管理方面的当前挑战。